Clinical trials of a simple and accurate blood test to detect early-stage ovarian cancer – key to boosting survival rates – ...
The immune systems of cancer patients are highly disrupted, with those who have a higher number of immune cells in their blood having a better survival rate, finds a new study that uses a pioneering ...
AVEO Oncology, an LG Chem company ("AVEO"), is a biopharmaceutical company that is trying to provide differentiated solutions to improve cancer patients lives, presented two posters during the 2025 ...
Million Private Placement Financing from Existing Investors$2.0 Million Funding Advance from the Cancer Prevention and Research Institute of ...
The immune systems of cancer patients are highly disrupted, with those who have a higher number of immune cells in their blood having a better survival rate, finds a new study that uses a pioneering ...
NT219, a novel agent designed to overcome tumor resistance to drug therapy, will be evaluated in combination with the standard-of-care head and ...
The immune systems of cancer patients are highly disrupted, with those who have a higher number of immune cells in their ...
Stanford scientists have identified 380 key genetic variants that significantly influence cancer development, filtering ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results